Predictive Factors for Response to New Oral Anticoagulants in the Treatment of Non-valvular Atrial Fibrillation..

NCT04297150 · clinicaltrials.gov ↗

UNKNOWN

Status

700

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Apixaban
DRUG: Edoxaban
DRUG: Rivaroxaban
DRUG: Dabigatran

Sponsor

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa